BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 89 filers reported holding BICYCLE THERAPEUTICS PLC in Q1 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,106,955 | +114.0% | 1,299,500 | +171.9% | 0.08% | +111.1% |
| Q2 2023 | $12,198,560 | -28.5% | 478,000 | -40.4% | 0.04% | -32.1% |
| Q1 2023 | $17,067,048 | -42.8% | 802,400 | -20.4% | 0.05% | -47.5% |
| Q4 2022 | $29,836,149 | +2.2% | 1,007,978 | -19.7% | 0.10% | -13.7% |
| Q3 2022 | $29,201,000 | +20.4% | 1,255,418 | -13.1% | 0.12% | +14.7% |
| Q2 2022 | $24,247,000 | -65.9% | 1,445,000 | -10.8% | 0.10% | -63.8% |
| Q1 2022 | $71,077,000 | -25.8% | 1,619,802 | +3.0% | 0.28% | -26.2% |
| Q4 2021 | $95,738,000 | +42.5% | 1,572,823 | -2.6% | 0.38% | +29.5% |
| Q3 2021 | $67,172,000 | +22.5% | 1,615,092 | -10.6% | 0.30% | +19.9% |
| Q2 2021 | $54,828,000 | +16.4% | 1,805,935 | +14.5% | 0.25% | +11.8% |
| Q1 2021 | $47,120,000 | +82.6% | 1,577,493 | +9.7% | 0.22% | +74.6% |
| Q4 2020 | $25,804,000 | -0.6% | 1,437,576 | +5.5% | 0.13% | -5.3% |
| Q3 2020 | $25,968,000 | +311.9% | 1,363,151 | +240.4% | 0.13% | +224.4% |
| Q2 2020 | $6,304,000 | +15.3% | 400,499 | 0.0% | 0.04% | -6.8% |
| Q1 2020 | $5,467,000 | +51.6% | 400,499 | +4.7% | 0.04% | +131.6% |
| Q4 2019 | $3,607,000 | – | 382,499 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
| GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
| Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
| Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
| First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
| Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
| Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
| Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
| Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |